检索:
选择日期:
  • 不限
  • 2025-05-29 [星期四]
  • 2025-05-30 [星期五]
  • 2025-05-31 [星期六]
选择会场:
  • 不限
  • Main venue
  • Sub-session 1
  • Sub-session 2
  • Sub-session 3
  • Sub-session 4
  • Meeting Room 1

2025-05-30 星期五

Sub-session 1

12:00-13:00 | Lunch Symposiums(Servier):A paradigm shift with the Opening of IDH Inhibition Era for mIDH Diffuse Glioma
编号 时间 题目 讲者 单位
1 12:00-12:15

Essentials of mIDH Diffuse Glioma: Understanding Specificities, Mechanism & Progression of mIDH Diffuse Gliomas

Mitchel S. Berger Medical Center, University of California, San Francisco (UCSF)
2 12:15-12:30

Targeting a Key Driver in mIDH Diffuse Gliomas

Wolfgang  Wick University of Heidelberg Medical Center/German Cancer Research Center
3 12:30-12:42

Insights and Findings from Regional Studies

Xiaohui Ren Chief Physician at the Department of Neurosurgery, Beijing Tiantan Hospital
13:00-15:30 | Glioma(I)
编号 时间 题目 讲者 单位
1 13:00-13:15

Long-term progression-free survival of patients with mutant isocitrate dehydrogenase 1 or 2 glioma receiving vorasidenib following surgery: results from a Phase 1 perioperative trial and the Phase 3 INDIGO trial

Wolfgang  Wick University of Heidelberg Medical Center/German Cancer Research Center
2 13:15-13:30

Exploring the Neuron-Glioma-Astrocyte Axis in IDH-Mutant Gliomas: Mechanisms, Therapies, and Insights

Hai Yan Institute of Molecular & Cell Biology (IMCB)
3 13:30-13:45

The Role of Glioma Stem Cells in Radiation Treatment Failure

Yifang Ping Southwest Hospital, Army Medical University
4 13:45-14:00

Tumor Treating Fields in Glioblastoma: A Deep Dive into Recent Clinical Breakthroughs

Xuejun Yang Beijing Tsinghua Changgung Hospital,Tsinghua University
5 14:00-14:15

Intraoperative Assessment of Glioma Using Miniaturized Epi-fluorescence Widefield Microscope: A Prospective Comparative Study of Ex-vivo and In-vivo Applications

Junxia Zhang Jiangsu Province Hospital
6 14:15-14:30

Total Therapy for Diffuse Midline Gliomas: A Potent Multi-Agent Sequential Treatment Strategy

Maria Tsoli University of New South Wales (UNSW), Sydney Australia
7 14:30-14:45

Locoregional Bi-specific CAR-T cells targeting CD44 and CD133 in Recurrent Glioblastoma: the results of the First-in-human clinical trial (NCT05577091)

Wei Zhang Beijing Tiantan Hospital ,Capital Medical University
8 14:45-15:00

A novel nuclear RNA HSD52 scaffolding NONO/SFPQ complex modulates DNA damage repair to facilitate temozolomide resistance

Jinquan Cai The Second Affiliated Hospital of Harbin Medical University
9 15:00-15:15

MSD Special Session:Diagnosis and Treatment of Rare Glioblastomas:Exploration and Insights

Ke Sai Sun Yat-sen University Cancer Center
10 15:15-15:30

MSD Special Session:Disscussion & Summarize

15:30-17:45 | Glioma(II)
编号 时间 题目 讲者 单位
1 15:30-15:45

Advantages of IORT in Intracranial Tumors

Vairavan Narayanan University Malaya Medical Centre
2 15:45-16:00

Quadratic Phenotypic Optimization Platform (QPOP) analysis of Patient-Derived Organoids (PDOs) in identifying effective chemotherapeutic combinations for the treatment of recurrent High Grade Glioma (HGG)

Yvonne LE Ang National University Cancer Institute Singapore
3 16:00-16:15

Novel Thalidomide Derivative AST-035A Shows Enhanced Anti-Tumor Efficacy against Glioblastoma as a Molecular Glue

Kihwan Hwang Seoul National University Bundang Hospital
4 16:15-16:30

Defining a comprehensive multi-omic/spectral plasma extracellular vesicles biomarker signature as a diagnostic liquid biopsy biomarker for glioma patients

Stephen Robinson
5 16:30-16:45

Advancing Survival of Recurrent Glioblastoma through Enhanced Drug Penetration via Focused Ultrasound-Induced Blood-Brain Barrier Modulation: A Systematic Review of Clinical Trials

Muhammad Alifian Remifta Putra Universitas Indonesia/Cipto Mangunkusumo National Hospital
6 16:45-17:00

Potential predictors of awake surgery failure for insular glioma

Shigeki Takada Kyoto University Graduate School of Medicine
7 17:00-17:15

Spatiotemporal proliferation activity mappingin gliomas via AQP4 water-exchange MRI

Yingchao Liu Shandong provincial hospital, Shandong First Medical University
8 17:15-17:30

Determinants of Poor Prognosis after Surgery for Glioblastoma Multiforme: A Retrospective Study of Causes of Morbidity and Mortality in a Low-Middle Income Context

Haseeb Mehmood Qadri Punjab Institute of Neurosciences, Lahore
9 17:30-17:45

Discussion & Summarize